AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

ADMA Biologics Inc. (ADMA)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

16.08

-0.11 (-0.68%)

At close: Jan 28, 2025, 1:58 PM

ADMA Biologics Inc. Revenue Breakdown

Quarter	Sep 30, 2024	Mar 31, 2024	Dec 31, 2023	Jun 30, 2023	Mar 31, 2023
ADMA BioManufacturing Segment Revenue	113.09M	80.11M	51.82M	59.76M	49.58M
ADMA BioManufacturing Segment Revenue Growth	+41.16%	+54.60%	-13.29%	+20.54%	n/a
Plasma Collection Centers Segment Revenue	7.45M	1.78M	488.76K	326.35K	7.30M
Plasma Collection Centers Segment Revenue Growth	+319.43%	+263.37%	+49.77%	-95.53%	n/a
Corporate Segment Revenue	36.00K	36.00K	n/a	35.71K	35.71K
Corporate Segment Revenue Growth	0.00%	n/a	n/a	0.00%	n/a

Revenue by Geography

Quarter	Dec 31, 2022
United States Revenue	146.43M
United States Revenue Growth	n/a

Operating Expense Breakdown

Quarter	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015	Mar 31, 2015
Selling, General, and Administrative Revenue	18.56M	17.55M	16.64M	16.22M	14.73M	14.25M	14.51M	13.89M	12.89M	11.97M	13.70M	11.70M	10.73M	10.44M	10.03M	9.30M	9.12M	8.70M	7.93M	7.03M	7.20M	6.09M	5.60M	7.14M	5.36M	5.01M	5.01M	5.18M	4.20M	4.44M	4.28M	3.28M	1.78M	1.72M	1.71M	1.88M	2.08M	1.44M	1.35M
Selling, General, and Administrative Revenue Growth	+5.75%	+5.44%	+2.61%	+10.15%	+3.36%	-1.82%	+4.44%	+7.77%	+7.71%	-12.62%	+17.11%	+9.05%	+2.77%	+4.03%	+7.89%	+2.03%	+4.75%	+9.71%	+12.80%	-2.29%	+18.26%	+8.77%	-21.58%	+33.23%	+6.97%	+0.04%	-3.46%	+23.57%	-5.41%	+3.70%	+30.27%	+84.56%	+3.19%	+0.95%	-9.37%	-9.33%	+44.57%	+6.79%	n/a
Research and Development Revenue	412.00K	560.00K	450.00K	445.49K	595.90K	1.40M	855.35K	1.07M	1.04M	873.39K	624.11K	728.99K	770.56K	1.16M	987.65K	1.01M	1.71M	1.66M	1.53M	464.82K	491.40K	516.99K	870.63K	-144.92K	1.32M	1.47M	1.28M	1.86M	1.81M	1.36M	1.19M	583.37K	1.68M	3.40M	2.03M	2.00M	2.11M	1.51M	1.40M
Research and Development Revenue Growth	-26.43%	+24.44%	+1.01%	-25.24%	-57.53%	+64.06%	-20.38%	+3.11%	+19.30%	+39.94%	-14.39%	-5.39%	-33.51%	+17.34%	-2.55%	-40.68%	+3.14%	+8.35%	+228.89%	-5.41%	-4.95%	-40.62%	-700.77%	-111.00%	-10.52%	+14.85%	-31.25%	+2.77%	+33.54%	+13.89%	+104.45%	-65.22%	-50.67%	+67.67%	+1.55%	-5.43%	+40.21%	+7.43%	n/a